Reduction in Serum High Mobility Group Box-1 Level by Polymyxin B-Immobilized Fiber Column in Patients with Idiopathic Pulmonary Fibrosis with Acute Exacerbation

Authors:
  • HHHiroki Hayashi
    Hiroki Hayashi
  • YSYoshitsugu Seo
    Yoshitsugu Seo
  • KMKuniko Matsuda
    Kuniko Matsuda
  • KKKoichiro Kamio
    Koichiro Kamio
  • YSYoshinobu Saito
    Yoshinobu Saito
  • JUJiro Usuki
    Jiro Usuki
  • SKShoji Kudo
    Shoji Kudo
  • AGAkihiko Gemma
    Akihiko Gemma

Abstract
Background/Aim: Recent reports suggest that polymyxin B (PMX)-immobilized fiber may have beneficial effects in idiopathic pulmonary fibrosis (IPF) with acute exacerbation (AE). High mobility group box-1 (HMGB-1) is an important pro-inflammatory mediator that contributes to acute lung inflammation. This study was aimed to investigate whether PMX treatment affects serum HMGB-1 levels and oxygenation in IPF patients with AE. Materials and Methods: Twenty IPF patients with AE were treated by PMX. PMX treatment was carried out once daily for 2 successive days. Serum HMGB-1 levels were measured before and after PMX treatment. We also monitored arterial oxygen tension (PaO2)/inspiratory oxygen fraction (FiO2) (P/F) ratio. PMX fiber columns were analyzed to examine whether HMGB-1 was absorbed by PMX. Results: PMX treatment significantly improved both the serum HMGB-1 level and P/F ratio. HMGB-1 was detected in washing medium from the PMX column. Conclusion: PMX treatment may reduce serum HMGB-1 and improve oxygenation in patients with IPF with AE.

This publication has 25 references indexed in Scilit: